BioSpace News Archive

Business

Siemens Healthineers to include Mentice VIST ® simulators with Corindus CorPath GRX Robotic PCI system (CorPath GRX) in China

Mentice and Siemens Healthineers China announce that Mentice VIST ® Virtual Patient simulators will be included with the sale of every Corindus CorPath GRX Robotic system (CorPath GRX) in China on an initial 3-year agreement, starting 2022.

December 27, 2021
·
3 min read
Business

Microbot Medical Announces Strategic Collaboration with Stryker Corporation to Develop the LIBERTY® Robotic System for Neurovascular Applications

Microbot Medical Inc. (Nasdaq: MBOT) announced that it has entered into a strategic collaboration agreement with Stryker, a leading global medical technology company.

December 27, 2021
·
3 min read
Business

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Approved in Japan for Patients With Unresectable, Advanced or Recurrent Endometrial Carcinoma That Progressed After Cancer Chemotherapy

KEYTRUDA ® (pembrolizumab) Plus LENVIMA ® (lenvatinib) Approved in Japan for Patients With Unresectable, Advanced or Recurrent Endometrial Carcinoma That Progressed After Cancer Chemotherapy.

December 27, 2021
·
67 min read
Drug Development

BridgeBio Pharma Reports Month 12 Topline Results from Phase 3 ATTRibute-CM Study

BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced topline results from Month 12 (Part A) of ATTRibute-CM, an ongoing global Phase 3 study investigating acoramidis for the treatment of symptomatic transthyretin (TTR) amyloid cardiomyopathy (ATTR-CM).

December 27, 2021
·
10 min read
Business

BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES

Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Brenda Everson as Senior Vice President, Human Resources effective January 10, 2022 .

December 27, 2021
·
1 min read
BioMidwest

Soin Therapeutics Completes Formulation Development of Novel Low Dose Naltrexone Tablet to Treat Complex Regional Pain Syndrome

Soin Therapeutics has completed the formulation development work of their novel, proprietary low dose naltrexone pill to treat Complex Regional Pain Syndrome (CRPS).

December 27, 2021
·
2 min read
Genetown

Moderna Announces Switzerland Exercises its Option to Purchase Seven Million Additional Doses of Moderna’s COVID-19 Booster Vaccine in 2022

Moderna, Inc. today announced that the Swiss Federal Government has exercised its option to purchase an additional seven million doses of Moderna’s booster vaccine for delivery in the second half of 2022.

December 27, 2021
·
3 min read
Biotech Bay

SI-BONE to participate in 24th Annual Needham Virtual Growth Conference

SI-BONE, Inc. today announced management is scheduled to participate in the following investor conference: 24th Annual Needham Virtual Growth Conference on Wednesday, January 12, 2022 at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time.

December 27, 2021
·
1 min read
Business

Former CFO of GSK’s Global Vaccines Business Mr. Jay Green Joins BiondVax’s Board of Directors

BiondVax Pharmaceuticals Ltd. today announced that all proposed resolutions were approved at today’s Annual General Meeting of Shareholders, including the election of Mr. Jay Green to the Company’s Board of Directors.

December 27, 2021
·
6 min read
Business

DANAHER SCHEDULES FOURTH QUARTER 2021 EARNINGS CONFERENCE CALL

Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2021 on Thursday, January 27, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour.

December 27, 2021
·
1 min read